US regulators on Monday revoked emergency authorization for malaria drugs promoted by US President Donald Trump for treating COVID-19, based on growing evidence that they do not work and could cause serious side effects.
The Food and Drug Administration said the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the FDA said the drugs’ unproven benefits “do not outweigh the known and potential risks.”
Full Story (The Times of Israel)
